BIOCITECH: Over 20% increase in revenue for the residents in 2014

04-May-2015 - Biocitech announced the 2014 results achieved by its residents. Biocitech residents submitted encouraging results for 2014, with growth in many areas. The overall revenue for the complex’s residents grew by 21%, from €51.3 million ($55.5 million) in 2013 to €62 million ($67 million) in 2014. Some ...

Metabolium names chief operating officer and chief scientific director

10-Apr-2015 - Metabolium announces the appointment of Dr. Khadidja Romari as chief operating officer and chief scientific director.Before joining the company, Romari spent several months as scientific advisor to Dominique Duvauchelle, CEO of Metabolium, to gain an understanding of the technologies developed by ...

Biocitech gives support to three start-ups in Bond’Innov initiative

01-Oct-2012 - Biocitech announced that it is giving its support to three new biotechnology start-ups based in the town of Bondy, near Paris. The announcement came after the official opening of Bond’Innov, an incubator backed by various public bodies and by Biocitech.Biocitech was one of the founding partners ...

Biocitech: Mutabilis receives EUR four million of EU funding for its HIVINNOV project

20-Sep-2012 - Mutabilis announced that it has received EUR four million of European funding for the HIVINNOV project, which is aimed at developing new antiretrovirals against HIV. The Mutabilis project, known as “Generation of a new class of antiretrovirals targeting HIV-cellular cofactors interactions”, or ...

Paris hospitals group, AP-HP, and Biocitech sign cooperation agreement

Partnership aims to speed development of early stage healthcare companies and increase opportunities for those with innovative projects from AP-HP or Biocitech

05-Jul-2012 - Biocitech and AP-HP announced that they have signed a cooperation agreement. The agreement was signed by Mireille Faugere, managing director of AP-HP and Jean-Francois Boussard, Biocitech president, at the ninth annual APinnov technology transfer conference in Paris.Together, the two partners ...

Biocitech residents continue to boost innovation in response to challenging economic times

12-Apr-2012 - Biocitech announced that the 27 enterprises based onsite continued to invest, innovate and sign contracts in 2011. Many indicators show positive growth, including the number of scientists, who now represent 317 out of 551 personnel working on the site.Innovation indicators in 2011 include nine ...

Helios BioSciences joins Biocitech technology park

Helios identifies therapeutic targets and biomarkers using its proprietary technology platform for predicting molecular interactions

08-Mar-2012 - Biocitech announced the arrival of Helios BioSciences, a provider of bioinformatics services in support of the drug discovery process. Helios BioSciences, which moved into the technology park in December, is the 27th company to locate there. This is further confirmation of Biocitech’s ...

Biocitech announces the arrival of BioBank for Life as new resident

08-Dec-2011 - Biocitech announced that BioBank for Life, a company dedicated to the storage of biological resources, is the latest life science company to take up residence at Biocitech. BioBank is the third new resident since the beginning of 2011. The company moved into the park in September this year and ...

PupPharma moves into the Biocitech science park

28-Jun-2011 - Biocitech announced the arrival of a new resident, PupPharma, which becomes the 27th company to set up shop there. PupPharma moved into the park in May, bringing a further expansion of the range of services along the health value chain provided by Biocitech and further confirming its ...

Biocitech welcomes new researchers from Pharma Omnium International

05-Jul-2010 - Biocitech announces the amalgamation on its campus of the anti-infective research teams of Pharma Omnium International, a French pharmaceutical company specialized in research into anti-infectives. Pharma Omnium International has considerably stepped up its research effort over the past 12 ...